BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jonas DE, Crotty K, Yun JDY, Middleton JC, Feltner C, Taylor-Phillips S, Barclay C, Dotson A, Baker C, Balio CP, Voisin CE, Harris RP. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;326:744-60. [PMID: 34427595 DOI: 10.1001/jama.2021.10403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu W, Li X, Zhong W, Dong S, Feng C, Yu B, Lin X, Yin Y, Chen T, Yang S, Jia P. Rural-urban disparities in the associations of residential greenness with diabetes and prediabetes among adults in southeastern China. Sci Total Environ 2023;860:160492. [PMID: 36435247 DOI: 10.1016/j.scitotenv.2022.160492] [Reference Citation Analysis]
2 He L, Fan B, Li C, Qu Y, Liu Y, Zhang T. Association between Body Mass Index and Diabetes Mellitus Are Mediated through Endogenous Serum Sex Hormones among Menopause Transition Women: A Longitudinal Cohort Study. IJERPH 2023;20:1831. [DOI: 10.3390/ijerph20031831] [Reference Citation Analysis]
3 Golovaty I, Ritchie ND, Tuomilehto J, Mohan V, Ali MK, Gregg EW, Bergman M, Moin T. Two Decades of Diabetes Prevention Efforts: A Call to Innovate and Revitalize Our Approach to Lifestyle Change. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.110195] [Reference Citation Analysis]
4 Lee WL, Wang PH, Yang ST, Liu CH, Chang WH, Lee FK. To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases. J Chin Med Assoc 2022;85:1109-19. [PMID: 36279128 DOI: 10.1097/JCMA.0000000000000831] [Reference Citation Analysis]
5 Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. The Lancet 2022. [DOI: 10.1016/s0140-6736(22)01655-5] [Reference Citation Analysis]
6 Sagastume D, Siero I, Mertens E, Cottam J, Colizzi C, Peñalvo JL. The effectiveness of lifestyle interventions on type 2 diabetes and gestational diabetes incidence and cardiometabolic outcomes: A systematic review and meta-analysis of evidence from low- and middle-income countries. eClinicalMedicine 2022;53:101650. [DOI: 10.1016/j.eclinm.2022.101650] [Reference Citation Analysis]
7 Mittal M, Jethwani P, Naik D, Garg MK. Non-medicalization of medical science: Rationalization for future. World J Methodol 2022; 12(5): 402-413 [DOI: 10.5662/wjm.v12.i5.402] [Reference Citation Analysis]
8 Jonas DE, Vander Schaaf EB, Riley S, Allison BA, Middleton JC, Baker C, Ali R, Voisin CE, LeBlanc ES. Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2022;328:968-79. [PMID: 36098720 DOI: 10.1001/jama.2022.7957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Su YC, Hung JH, Chang KC, Sun CC, Huang YH, Lee CN, Hung MJ, Lai CC, Shao SC, Lai EC. Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan. JAMA Netw Open 2022;5:e2232584. [PMID: 36136333 DOI: 10.1001/jamanetworkopen.2022.32584] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Su Y, Huang J, Chu C, Wei JC. Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: A nationwide cohort study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.934184] [Reference Citation Analysis]
11 Choi G, Yoon H, Choi HH, Ha KH, Kim DJ. Association of prediabetes with death and diabetic complications in older adults: the pros and cons of active screening for prediabetes. Age Ageing 2022;51:afac116. [PMID: 35737599 DOI: 10.1093/ageing/afac116] [Reference Citation Analysis]
12 Schulze MB, Hu FB. Epidemiology of Diabetes. Handbook of Epidemiology 2022. [DOI: 10.1007/978-1-4614-6625-3_66-1] [Reference Citation Analysis]
13 . Prädiabetes und Typ-2-Diabetes: Wie effektiv sind heutige Screening-Programme? Diabetologie und Stoffwechsel 2021;16:438-40. [DOI: 10.1055/a-1647-6600] [Reference Citation Analysis]
14 White S, Gong H, Zhu L, Doust J, Loh TP, Lord S, Andrea ARH, Mcgeechan K, Bell K. Simulations found within-subject measurement variation in glycaemic measures may cause overdiagnosis of prediabetes and diabetes. Journal of Clinical Epidemiology 2021. [DOI: 10.1016/j.jclinepi.2021.12.025] [Reference Citation Analysis]
15 Cavender MA, Wirka RC. Blood pressure lowering in the prevention of type 2 diabetes. Lancet 2021;398:1778-9. [PMID: 34774133 DOI: 10.1016/S0140-6736(21)02340-0] [Reference Citation Analysis]
16 Misra A, Ramachandran A, Saboo B, Kesavadev J, Sosale A, Joshi S, Das AK. Screening for diabetes in India should be initiated at 25 years age. Diabetes Metab Syndr 2021;15:102321. [PMID: 34739907 DOI: 10.1016/j.dsx.2021.102321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhang YT, Zeeshan M, Su F, Qian ZM, Dee Geiger S, Edward McMillin S, Wang ZB, Dong PX, Ou YQ, Xiong SM, Shen XB, Zhou PE, Yang BY, Chu C, Li QQ, Zeng XW, Feng WR, Zhou YZ, Dong GH. Associations between both legacy and alternative per- and polyfluoroalkyl substances and glucose-homeostasis: The Isomers of C8 health project in China. Environ Int 2021;158:106913. [PMID: 34624590 DOI: 10.1016/j.envint.2021.106913] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]